Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”
| 發表在: | Clinical and Molecular Hepatology |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Korean Association for the Study of the Liver
2025-01-01
|
| 主題: | |
| 在線閱讀: | http://e-cmh.org/upload/pdf/cmh-2024-0830.pdf |